Clarity in the Fog
of Diagnostic
Commercialization
Experienced navigators helping diagnostic founders convert scientific validation into repeatable clinical adoption.
Our Framework
Building the Infrastructure
for Diagnostic Adoption
A structured approach to turning scientific validation into repeatable market adoption.
Evidence Strategy
Design clinical and economic evidence aligned with payer and physician decision criteria.
Market Access Architecture
Define reimbursement pathways, regulatory sequencing, and care-setting placement.
Adoption Infrastructure
Build the commercial systems required for physician engagement and scalable adoption.
Commercial Readiness
Clearance Does Not
Create Adoption
Regulatory progress advances the product. It does not establish commercial readiness.
Unclear launch sequencing
Evidence not payer-aligned
Channel decisions delayed
Pricing defined too late
Activity without repeatable adoption
Investor pressure increasing
This is where commercialization risk begins.
The greatest risk in diagnostics is not scientific failure.It is the failure to reach clinical adoption.We build the bridge.
The Diagnostic Commercialization Bridge
The Commercial Architecture Framework
Three Phases of Diagnostic Commercialization Architecture
Strategic Audit
Diagnose before you build
Every engagement begins with a rigorous assessment of commercialization readiness. We evaluate your evidence portfolio, reimbursement positioning, channel strategy, and launch sequencing to identify the structural gaps between regulatory progress and sustainable clinical adoption. The Strategic Audit produces a prioritized architecture brief that sequences your next 90 days of commercial decisions.
Learn about our diagnostic sprintStructural Design
Architecture, not advice
Traditional consulting delivers recommendations. Commercialization architecture delivers infrastructure. We design the operating model, pricing logic, channel architecture, and evidence strategy required to convert FDA clearance into repeatable clinical adoption. Each layer resolves before the next begins, so commercial investment compounds on structure rather than assumption.
Explore the full frameworkGuided Execution
From blueprint to adoption
Architecture without execution is decoration. We install the launch sequencing, field strategy, and stakeholder alignment systems that translate strategy into contracted clinical use. From first pilot placement through national distribution, AdvisoryDx provides the operational infrastructure that sustains adoption velocity beyond the initial commercial window.
See our engagement modelThe Pathfinding Process
From Diagnostic to Commercial Readiness
The Illuminator
See the full landscape before you commit capital
Map current commercialization readiness across evidence, channel, and pricing dimensions
Identify the single most critical commercial risk before funding or launch milestones
Benchmark positioning against competitive and reimbursement landscape dynamics
Deliver a prioritized architecture brief with sequenced 90-day action plan
The Foundation
Build the commercial operating system
Design pricing architecture anchored to clinical utility and workflow economics
Structure reimbursement strategy aligned to CPT/PLA coding pathways
Define care-setting priorities and buyer pathway sequencing for market entry
Install evidence strategy that converts analytical claims into payer-ready utility data
The Blueprint
Execute with precision, not assumption
Operationalize launch sequencing from regulatory clearance to first contracted adoption
Deploy field strategy with evidence-based sales enablement and ROI frameworks
Build distributor selection criteria, margin architecture, and channel governance
Align investor narrative with commercial milestones and adoption metrics
Who We Support
Diagnostic Innovators We Serve
Early-Stage Biotech Startups
Navigating first regulatory and commercial milestones with breakthrough assays.
Clinical Labs Scaling Operations
Expanding test menus or entering new clinical segments with validated platforms.
IVD Manufacturers Entering New Markets
Building market entry strategies for cleared or near-cleared diagnostic products.
Methodology
Why Architecture,
Not Consulting.
Traditional consulting delivers recommendations. Architecture delivers infrastructure. The difference is the gap between a strategy deck and a functioning commercial system.
Our methodology sequences six decision layers, each resolving before the next begins, so commercial investment lands on structure rather than assumption.
The result: diagnostic companies that launch with the operating model, pricing architecture, and channel logic already validated, not retroactively assembled after clearance.
The Six Layers
Defining the market you will own and the category position that drives adoption.
Aligning clinical and economic data to payer and physician decision logic.
Designing the distribution pathway that matches your product to its buyer.
Building the coverage and coding foundation that unlocks sustainable revenue.
Staging market entry so every resource compounds toward early traction.
Ensuring your commercial story holds up to diligence from funders and partners.
Strategic Resource
Commercialization Architecture for Diagnostics
A structured framework for navigating the gap between FDA clearance and repeatable clinical adoption. Enter your email to download the full briefing.
Next Step
Entering the Commercialization Window?
Diagnostic companies often reach clinical validation without installing the commercial architecture required for adoption.
AdvisoryDx works with founders and investors to design commercialization strategy before launch decisions become irreversible.
30-minute diagnostic conversation. No preparation required.